{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:36:16Z","timestamp":1786653376414,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Liaoning Province Educational Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008844","name":"Liaoning University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015397","name":"Inner Mongolia Autonomous Region Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.fitote.2026.107421","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:36:52Z","timestamp":1786059412000},"page":"107421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cyclovirobuxine D: A full research chain review covering extraction, quantitative analysis, pharmacology, toxicology, pharmacokinetics and formulation development"],"prefix":"10.1016","volume":"193","author":[{"given":"Fantong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.fitote.2026.107421_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400494","article-title":"Phytochemistry of genus Buxus and pharmacology of Cyclovirobuxine D","volume":"21","author":"Li","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.fitote.2026.107421_bb0010","series-title":"Study on Detection and Preparation Technology of Cyclovirobuxine D","author":"Wang","year":"2019"},{"key":"10.1016\/j.fitote.2026.107421_bb0015","series-title":"Draft of General Chapters of Chinese Pharmacopoeia 2020 Edition, Volume IV","author":"N.P. Commission","year":"2025"},{"issue":"02","key":"10.1016\/j.fitote.2026.107421_bb0020","first-page":"264","article-title":"HPLC determination of content and uniformity of cyclovirobuxine D in Huangyangning tablets","volume":"27","author":"Huang","year":"2007","journal-title":"J. Pharm. Anal."},{"issue":"3","key":"10.1016\/j.fitote.2026.107421_bb0025","first-page":"52","article-title":"Determination of Cyclovirobuxium D in Huangyangning tablets by HPLC-ELSD","volume":"28","author":"Lv","year":"2014","journal-title":"Modern Res. Practice Traditional Chin. Med."},{"key":"10.1016\/j.fitote.2026.107421_bb0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jpba.2006.04.025","article-title":"High performance liquid chromatography- tandem mass spectrometric determination of cyclovirobuxine D in human plasm","volume":"42","author":"Yu","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.fitote.2026.107421_bb0035","first-page":"190","article-title":"The study of improving the assay method of Cyclovirobuxine D","volume":"14","author":"Jin","year":"2012","journal-title":"Chin. Pharm. Stand."},{"key":"10.1016\/j.fitote.2026.107421_bb0040","first-page":"419","article-title":"Rapid determination of cyclovirobuxined in human plasma by HPLC-MS and it's pharmacokinetics study, Tianjin","volume":"05","author":"He","year":"2008","journal-title":"J. Tradit. Chin. Med."},{"issue":"11","key":"10.1016\/j.fitote.2026.107421_bb0045","first-page":"1098","article-title":"Determination of Cyclovirobuxine D in Huangyangning tablets by TLCS","volume":"16","author":"Liu","year":"2005","journal-title":"Shi Zhen Traditional Chin. Med."},{"issue":"4","key":"10.1016\/j.fitote.2026.107421_bb0050","first-page":"21","article-title":"Separation and purification methods of main alkaloids in Huangyangning","volume":"30","author":"Xu","year":"2009","journal-title":"Animal Husbandry Feed Sci."},{"key":"10.1016\/j.fitote.2026.107421_bb0055","article-title":"Cyclovirobuxine D induces apoptosis and mitochondrial damage in glioblastoma cells through ROS-mediated mitochondrial translocation of Cofilin","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.fitote.2026.107421_bb0060","first-page":"807","article-title":"Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low-grade glioma","volume":"43","author":"Zhou","year":"2020","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.fitote.2026.107421_bb0065","first-page":"183","article-title":"Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1-AKT\/ERK-snail signaling pathway","volume":"57","author":"Jiang","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"13","key":"10.1016\/j.fitote.2026.107421_bb0070","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.7150\/ijbs.62114","article-title":"Cyclovirobuxine D inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT\/STAT3\/MAPK-snail signalling pathway","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.fitote.2026.107421_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/dna.2019.4990","article-title":"Cyclovirobuxine D exerts anticancer effects by suppressing the EGFR-FAK-AKT\/ERK1\/2-slug signaling pathway in human hepatocellular carcinoma","volume":"39","author":"Zhang","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"6","key":"10.1016\/j.fitote.2026.107421_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70227","article-title":"Targeting LIF with cyclovirobuxine D to suppress tumor progression via LIF\/p38MAPK\/p62-modulated mitophagy in hepatocellular carcinoma","volume":"6","author":"Shao","year":"2020","journal-title":"MedComm"},{"issue":"11","key":"10.1016\/j.fitote.2026.107421_bb0085","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.3390\/molecules201119729","article-title":"Cyclovirobuxine D inhibits cell proliferation and induces mitochondria-mediated apoptosis in human gastric Cancer cells","volume":"20","author":"Wu","year":"2015","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.fitote.2026.107421_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115820","article-title":"Cyclovirobuxine D induced-Mitophagy through the p65\/BNIP3\/LC3 Axis potentiates its apoptosis-inducing effects in lung Cancer cells","volume":"22","author":"Zeng","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.fitote.2026.107421_bb0095","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5505","article-title":"Cyclovirobuxine D inhibits growth and progression of non-small cell lung cancer cells by suppressing the KIF11-CDC25C-CDK1-CyclinB1 G(2)\/M phase transition regulatory network and the NF\u03baB\/JNK signaling pathway","volume":"62","author":"Xue","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.fitote.2026.107421_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1254\/jphs.14013FP","article-title":"Cyclovirobuxine D induces autophagy-associated cell death via the Akt\/mTOR pathway in MCF-7 human breast cancer cells","volume":"125","author":"Lu","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.fitote.2026.107421_bb0105","article-title":"Cyclovirobuxine D suppresses cancer stemness in osteosarcoma with implication of the noncanonical NF-kappaB pathway","volume":"17","author":"Guo","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2026.107421_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156204","article-title":"Assessment of anti-cancer activity of cyclovirobuxine D in nasopharyngeal carcinoma cells: involvement of KIF23-mediated Akt\/mTOR pathway","volume":"275","author":"Li","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"21","key":"10.1016\/j.fitote.2026.107421_bb0115","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1111\/bph.16494","article-title":"Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3\/YAP axis","volume":"181","author":"Liu","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"01","key":"10.1016\/j.fitote.2026.107421_bb0120","first-page":"20","article-title":"Effects of combination of cyclovirobuxine D and waabain on contractility of isolated myocardium","volume":"29","author":"Wang","year":"1994","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.fitote.2026.107421_bb0125","first-page":"388","article-title":"Experimental research of Cyclovirbuxine-D increasing intracellular free Ca2+ of myocardium","volume":"05","author":"Liang","year":"2001","journal-title":"J. Li-shizhen Traditional Chin. Med."},{"key":"10.1016\/j.fitote.2026.107421_bb0130","first-page":"1010","article-title":"Electrophysiologic study of the biphasic effects of Cyclovirobuxine D on arrhythmias","volume":"11","author":"Chen","year":"2004","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"10.1016\/j.fitote.2026.107421_bb0135","first-page":"111","article-title":"Positive inotropic effect of cyclovirobuxine D on isolated myocardium of guinea pigs","volume":"02","author":"Wang","year":"1989","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.fitote.2026.107421_bb0140","first-page":"295","article-title":"The positive inotropic effect of cyclovirobuxine D on myocardial and the inhibitory effect of Na+-K+-ATPase activity in cell membrane","volume":"03","author":"Wen","year":"1982","journal-title":"Acta Physiologica Sinica"},{"key":"10.1016\/j.fitote.2026.107421_bb0145","series-title":"Changes of Myocardial Mechanics in Diabetic Rats and Effects of Cyclovirobuxine D, the 15th South China International Conference on Cardiovascular Diseases, Guangdong Guangzhou, China","author":"Chen","year":"2013"},{"key":"10.1016\/j.fitote.2026.107421_bb0150","first-page":"255","article-title":"The effect of cyclovirobuxine D on cardiac function and blood pressure in rats","volume":"04","author":"Yang","year":"2007","journal-title":"Chin. J. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.fitote.2026.107421_bb0155","first-page":"101","article-title":"Some cardiovascular effects of cyclovirobuxine D","volume":"3","author":"Liang","year":"2001","journal-title":"Chin. Pharmacol. J."},{"issue":"07","key":"10.1016\/j.fitote.2026.107421_bb0160","first-page":"2","article-title":"Anti-atrial fibrillation effect of cyclovirobuxine D and its electrophysiological mechanism","volume":"31","author":"Wang","year":"1996","journal-title":"Acta Pharm. Sin."},{"issue":"5","key":"10.1016\/j.fitote.2026.107421_bb0165","first-page":"310","article-title":"Effect of Huangyangning enhanced tablet on antiarrhythmia andcoronary blood flow increasing","volume":"10","author":"Zhang","year":"2001","journal-title":"Chin. J. Clin. Pharm."},{"key":"10.1016\/j.fitote.2026.107421_bb0170","first-page":"63","article-title":"Protective effects of cyclovirobuxine-D on experimental arrhythmia and myocardial ischemia","volume":"01","author":"Wang","year":"2003","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fitote.2026.107421_bb0175","series-title":"Therapeutic Effects of CVB-D on Rats with Heart Failure and Itseffect on the Expression of Myocardial Na-K-ATPase Subunit","author":"Haung","year":"2013"},{"issue":"12","key":"10.1016\/j.fitote.2026.107421_bb0180","first-page":"1562","article-title":"Therapeutic effects of Cyclovirobuxine D on rats with heart failure","volume":"33","author":"Huang","year":"2014","journal-title":"Herald Med."},{"issue":"17","key":"10.1016\/j.fitote.2026.107421_bb0185","doi-asserted-by":"crossref","first-page":"Pl255","DOI":"10.1016\/S0024-3205(97)00779-0","article-title":"Hemodynamic effects of the intravenous administration of cyclovirobuxine D in anesthetized pigs","volume":"61","author":"Vacca","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.fitote.2026.107421_bb0190","doi-asserted-by":"crossref","unstructured":"E. Grossini, A. Battaglia, S. Brunelleschi, etal, Coronary effects of cyclovirobuxine D in anesthetized pigs and in isolated porcine coronary arteries, Life Sci. 65(5) (1999) Pl59-Pl65.","DOI":"10.1016\/S0024-3205(99)00278-7"},{"issue":"01","key":"10.1016\/j.fitote.2026.107421_bb0195","first-page":"70","article-title":"Study on the non-endothelium-dependent vasodilatory effect of cyclovirobuxine D on thoracic aorta in rats and its mechanism","volume":"33","author":"Shen","year":"2017","journal-title":"Pharmacol. Clin. Chin. Materia"},{"key":"10.1016\/j.fitote.2026.107421_bb0200","series-title":"Effect of Cyclovirobuxine-D on Heart Function and Bloodpressure of Rats In Vivo","author":"Yang","year":"2007"},{"issue":"4","key":"10.1016\/j.fitote.2026.107421_bb0205","first-page":"15","article-title":"Effect of cyclovirobuxine D on microcirculation","volume":"16","author":"Shen","year":"2000","journal-title":"Pharmacol. Clin. Chin. Materia"},{"key":"10.1016\/j.fitote.2026.107421_bb0210","first-page":"14-17+75","article-title":"Effect of cyclovirobuxine D on atrioventricular conduction: a comparative study with lidocaine","volume":"01","author":"Xiao","year":"1984","journal-title":"J. Nanjing Med. Univ. (Natural Sciences)"},{"key":"10.1016\/j.fitote.2026.107421_bb0215","first-page":"623","article-title":"Effect of cyclovirobuxinum-D on cerebral ischemia-reperfusion injury in rats","volume":"07","author":"Yu","year":"2007","journal-title":"China J. Chin. Materia Medica"},{"key":"10.1016\/j.fitote.2026.107421_bb0220","first-page":"13","article-title":"Protective effect of cyclovirobuxine Don experimental cerebral ischemia, pharmacology and clinics of Chinese Materia","volume":"05","author":"Tao","year":"2003","journal-title":"Medica"},{"key":"10.1016\/j.fitote.2026.107421_bb0225","first-page":"10","article-title":"The neuroprotection of resveratrol in the experimental cerebral ischemia","volume":"7","author":"Wang","year":"2003","journal-title":"Natl. Med. J. China"},{"key":"10.1016\/j.fitote.2026.107421_bb0230","first-page":"113","article-title":"Effects of Cyclovirobuxine-D on Hemorrheology in rats with and withoutMyocardial ischemia, Chinese","volume":"02","author":"Wang","year":"1995","journal-title":"J. Hypertens."},{"key":"10.1016\/j.fitote.2026.107421_bb0235","first-page":"628","article-title":"Influnces of cyclovirobuxine-D on cardiac haemodynamics and experimental myocardial ischemia of anesthetic dogs","volume":"08","author":"Chen","year":"2005","journal-title":"Chin. Pharm."},{"issue":"4","key":"10.1016\/j.fitote.2026.107421_bb0240","first-page":"16","article-title":"Study on the cardiovascular effects of boxnine for injection","volume":"21","author":"Ye","year":"2005","journal-title":"Pharmacol. Clin. Chin. Mater. Med."},{"key":"10.1016\/j.fitote.2026.107421_bb0245","first-page":"91","article-title":"Observation on nephrotoxicity of cyclovirobuxine D in rats","volume":"02","author":"Xu","year":"2007","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"issue":"13","key":"10.1016\/j.fitote.2026.107421_bb0250","first-page":"1341","article-title":"Protective effect of cyclovirobuxine D on mice suffered from doxorubicin-induced cardiotoxicity","volume":"35","author":"Guo","year":"2013","journal-title":"J. Army Med. Univ."},{"key":"10.1016\/j.fitote.2026.107421_bb0255","series-title":"The role of mitochondrial function regulation in the anti-doxorubicin cardiotoxicity of cyclovirobuxine D, The 6th National Toxicology Congress of the Chinese Society of Toxicology, Guangzhou, Guangdong, China","first-page":"2","author":"Q","year":"2013"},{"issue":"09","key":"10.1016\/j.fitote.2026.107421_bb0260","first-page":"1632","article-title":"Protective effects of CVB-D on cardiac myocytes injury induced by high Sympathesis activity in vitro","volume":"37","author":"Wang","year":"2014","journal-title":"J. Chin. Med. Mater."},{"issue":"16","key":"10.1016\/j.fitote.2026.107421_bb0265","first-page":"1631","article-title":"Effect of cyclovirobuxine D on L-type calcium channels in rat atrial myocytes damaged by H2O2","volume":"41","author":"Wang","year":"2020","journal-title":"Guangdong Med. J."},{"issue":"02","key":"10.1016\/j.fitote.2026.107421_bb0270","first-page":"169","article-title":"Protective effect of cyclovirobuxine D on aldosterone-induced myocardial hypertrophy and apoptosis and its mechanism","volume":"49","author":"D","year":"2024","journal-title":"J. Guizhou Med. Univ."},{"issue":"01","key":"10.1016\/j.fitote.2026.107421_bb0275","first-page":"163","article-title":"Keap1-Nrf2 signaling is regulated by cyclovirobuxine D to improve the oxidative stress injury of primary cardiomyocytes induced by aldosterone","volume":"44","author":"Yang","year":"2021","journal-title":"J. Chin. Med. Mater."},{"key":"10.1016\/j.fitote.2026.107421_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157645","article-title":"Cyclovirobuxine D ameliorates cardiac hypertrophy by enhancing mitochondrial function via miR-30b-5p\/ALCAT1 pathway","volume":"150","author":"Zhang","year":"2026","journal-title":"Phytomedicine"},{"issue":"06","key":"10.1016\/j.fitote.2026.107421_bb0285","first-page":"554","article-title":"Influence of cyclovirobuxine D on neonatal rat cardiomyocytes injury induced by NaCN","volume":"30","author":"Y","year":"2014","journal-title":"J. Nanjing Univ. Chin. Med."},{"issue":"3","key":"10.1016\/j.fitote.2026.107421_bb0290","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.scib.2020.08.035","article-title":"Cyclovirobuxine D inhibits dengue virus replication by impeding the complete autophagy in a cholesterol-dependent manner","volume":"66","author":"Wang","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.fitote.2026.107421_bb0295","first-page":"37","article-title":"Protective effect of CBV-D on Glu-induced injury in cultured PC12 cells","volume":"01","author":"Yuan","year":"2004","journal-title":"Chin. J. Integr. Med. Cardio-Cerebrovascular Dis."},{"issue":"91","key":"10.1016\/j.fitote.2026.107421_bb0300","first-page":"39","article-title":"Preliminary study on hepatotoxicity of cyclovirobuxine D in female rats","volume":"17","author":"Dai","year":"2017","journal-title":"World Latest Med. Inform."},{"key":"10.1016\/j.fitote.2026.107421_bb0305","series-title":"Study of Cyclovirobuxine D Controlled-Release Tablets, Pharmacokinetics and Pharmacodynamics of Its PEG Derivatives","author":"Liang","year":"2008"},{"issue":"1","key":"10.1016\/j.fitote.2026.107421_bb0310","first-page":"26","article-title":"Study on the pharmacokinetics of 3H-cycloevergreen boxylline D in mice","volume":"13","author":"Lei","year":"1982","journal-title":"J. Sichuan Univ. (Med. Sci.)"},{"key":"10.1016\/j.fitote.2026.107421_bb0315","first-page":"6","article-title":"Study on metabolism of 3H-cyclovirobuxine D in rats","volume":"04","author":"Wang","year":"1982","journal-title":"Chin. Pharm. J."},{"issue":"06","key":"10.1016\/j.fitote.2026.107421_bb0320","first-page":"640","article-title":"Release and percutaneous penetration of Cyclovirobuxine D transdermal patch in vitro","volume":"35","author":"Liu","year":"2016","journal-title":"Herald Med."},{"issue":"12","key":"10.1016\/j.fitote.2026.107421_bb0325","first-page":"2114","article-title":"Pharmacokinetics of cyclovirobuxine D for injection in healthy volunteers","volume":"28","author":"Xue","year":"2008","journal-title":"Chin. J. Pharm. Anal."},{"issue":"10","key":"10.1016\/j.fitote.2026.107421_bb0330","first-page":"785","article-title":"Pharmacokinetic study of Huangyangning sustained-release capsules in dogs","volume":"26","author":"Wang","year":"2009","journal-title":"Chin. J. Mod. Appl. Pharm."},{"issue":"S1","key":"10.1016\/j.fitote.2026.107421_bb0335","first-page":"56","article-title":"Preparation and quality control of cyclovirobuxine D dispersion tablets","volume":"21","author":"Nie","year":"2004","journal-title":"Chin. J. Modern Appl. Pharm."},{"key":"10.1016\/j.fitote.2026.107421_bb0340","first-page":"94","article-title":"Study on preparation technology of cyclovirobuxine D sublingual tablet, scientific and technological","volume":"27","author":"Zhang","year":"2014","journal-title":"Innovation"},{"issue":"03","key":"10.1016\/j.fitote.2026.107421_bb0345","first-page":"290","article-title":"Study on formulation Design of Cyclovirobuxine D Sublingual Tablets","volume":"9","author":"Zhang","year":"2014","journal-title":"J. Chengdu Med. College"},{"issue":"10","key":"10.1016\/j.fitote.2026.107421_bb0350","first-page":"2555","article-title":"Preparation and prescription optimization of cyclovirobuxine Dinclusion complex microporous permeation pump controlled release tablets","volume":"42","author":"Wang","year":"2020","journal-title":"Chin. Traditional Patent Med."},{"key":"10.1016\/j.fitote.2026.107421_bb0355","first-page":"1120","article-title":"Study on moulding technics of Huangyangning dropping pills","volume":"12","author":"Gui","year":"2005","journal-title":"Chin. J. Hosp. Pharm."},{"key":"10.1016\/j.fitote.2026.107421_bb0360","series-title":"Studies on CVB-D Sustained-Release Pellets","author":"Yao","year":"2004"},{"issue":"07","key":"10.1016\/j.fitote.2026.107421_bb0365","first-page":"825","article-title":"Studies of in vitro releasing properties on cyclovirobuxine D matrix-type patch","volume":"34","author":"Yu","year":"2009","journal-title":"China J. Chin. Materia Medica"},{"issue":"10","key":"10.1016\/j.fitote.2026.107421_bb0370","first-page":"835","article-title":"Study on release degree of buxnine sustained release capsule","volume":"26","author":"Ye","year":"2009","journal-title":"Chin. J. Mod. Appl. Pharm."},{"key":"10.1016\/j.fitote.2026.107421_bb0375","first-page":"683","article-title":"Recent advances in clinical and experimental research on Cyclovirobuxine D","volume":"07","author":"Gu","year":"2005","journal-title":"China J. Emerg. Traditional Chin. Med."},{"key":"10.1016\/j.fitote.2026.107421_bb0380","first-page":"141","article-title":"Bioavailability and bioequivalence of cyclovirobuxine-D dispersible tablets in humans","volume":"02","author":"Hao","year":"2008","journal-title":"Military Med. Sci."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X26003400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X26003400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:16Z","timestamp":1786649776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X26003400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":76,"alternative-id":["S0367326X26003400"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2026.107421","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclovirobuxine D: A full research chain review covering extraction, quantitative analysis, pharmacology, toxicology, pharmacokinetics and formulation development","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2026.107421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107421"}}